“ViVa has been adopted in Uganda as a vaccine stock status dashboard for the Central Vaccine Store (CVS). ViVa is a permanent agenda item discussed in the monthly EPI vaccine management meeting.
In 2016, there was a sudden increase in the uptake of TT vaccine following addition of a new cohort (safe male circumcision). ViVa showed that the TT stock was to run out by end of November. In addition, we saw that a confirmed order of 1.8 million doses was expected only in January 2017. Therefore, a decision was made by the vaccine management meeting to ask the UNICEF Supply Chain Manager to expedite delivery by adjusting delivery date from Jan 2017 to Dec 2016."